Literature DB >> 20614331

Molecular diagnosis in head and neck: what a surgical pathologist must know.

Jennifer L Hunt1.   

Abstract

Molecular alterations in tumors have become interesting targets both for diagnostic and for therapeutic and prognostic applications in tumor pathology. In the head and neck, there are a variety of different alterations, encompassing all the different types of genetic events associated with carcinogenesis. This paper reviews three different types of tumors that display a spectrum of genetic alterations: the translocation in Mucoepidermoid carcinoma, Epstein Barr virus association in nasopharyngeal carcinoma, and the HRPT2 tumor suppressor gene in parathyroid carcinoma. Basic histology is reviewed and the genetic alterations are discussed, along with a brief discussion of potential diagnostic implications.

Entities:  

Keywords:  Lymphoepithelial carcinoma; Mucoepidermoid carcinoma; Nasopharyngeal carcinoma; Parathyroid carcinoma; Tumor markers

Mesh:

Substances:

Year:  2008        PMID: 20614331      PMCID: PMC2807553          DOI: 10.1007/s12105-008-0041-x

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  46 in total

1.  Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan.

Authors:  M H Ward; W H Pan; Y J Cheng; F H Li; L A Brinton; C J Chen; M M Hsu; I H Chen; P H Levine; C S Yang; A Hildesheim
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

2.  Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities.

Authors:  Yung-Ming Jeng; Ming-Tse Sung; Chia-Lang Fang; Hsuan-Ying Huang; Tsui-Lien Mao; Wei Cheng; Cheng-Hsiang Hsiao
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

3.  Midline destructive lesions of the sinonasal tract: simplified terminology based on histopathologic criteria.

Authors:  A Borges; J Fink; P Villablanca; R Eversole; R Lufkin
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

4.  Weight of normal parathyroid glands in patients with parathyroid adenomas.

Authors:  Kathy Yao; Frederick R Singer; Sanford I Roth; Aaron Sassoon; Cynthia Ye; Armando E Giuliano
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

5.  A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer.

Authors:  Filomena Cetani; Elena Pardi; Paolo Viacava; Giada Di Pollina; Giovanni Fanelli; Antonella Picone; Simona Borsari; Elisabetta Gazzerro; Paolo Miccoli; Piero Berti; Aldo Pinchera; Claudio Marcocci
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

6.  A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands.

Authors:  Carmo Martins; Branca Cavaco; Giovanni Tonon; Frederic J Kaye; Jorge Soares; Isabel Fonseca
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

Review 7.  Parathyroid carcinoma.

Authors:  Kirt S Beus; Brendan C Stack
Journal:  Otolaryngol Clin North Am       Date:  2004-08       Impact factor: 3.346

8.  Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

Authors:  Filomena Cetani; Elena Ambrogini; Paolo Viacava; Elena Pardi; Giovanni Fanelli; Antonio Giuseppe Naccarato; Simona Borsari; Monica Lemmi; Piero Berti; Paolo Miccoli; Aldo Pinchera; Claudio Marcocci
Journal:  Eur J Endocrinol       Date:  2007-05       Impact factor: 6.664

9.  Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.

Authors:  Trisha M Shattuck; Stiina Välimäki; Takao Obara; Randall D Gaz; Orlo H Clark; Dolores Shoback; Margaret E Wierman; Katsuyoshi Tojo; Christiane M Robbins; John D Carpten; Lars-Ove Farnebo; Catharina Larsson; Andrew Arnold
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

Review 10.  Nasopharyngeal carcinomas: an update.

Authors:  J-P Spano; P Busson; D Atlan; J Bourhis; J-P Pignon; C Esteban; J-P Armand
Journal:  Eur J Cancer       Date:  2003-10       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.